The 5 references without contexts in paper V. Sergeev G., M. Tanaeva S., T. Sergeeva N., V. Chuchkov M., В. Сергеев Г., М. Танаева С., Т. Сергеева Н., В. Чучков М. (2019) “Влияние бактериофагального инфицирования микробиоты на экспрессию альфа-синуклеина в стенке кишечника крыс // Influence of Bacteriophage Infections of Microbiota on the Expression of alpha-synuclein in the Rat Intestinal Wall” / spz:neicon:anatomy:y:2018:i:4:p:61-66

6
Farrer M. J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet. 2006; 7(4): 306–318 .
(check this in PDF content)
7
Forsyth C. B, Shannon K. M., Kordower J. H. et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS One. 2011; 6(12):e28032.
(check this in PDF content)
12
Natividad J., Verdu E. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol. Res. 2013; 69: 42–51.
(check this in PDF content)
14
Paillusson S., Clairembault T., Biraud M., Neunlist M., Derkinderen P. Activity-dependent secretion of alpha-synuclein by enteric neurons. J Neurochem. 2013; 125(4): 512–517.
(check this in PDF content)
16
Sommer F., Bäckhed F. The gut microbiota — masters of host development and physiology. Nat. Rev. Microbiol. 2013; 11: 227–238.
(check this in PDF content)